Home›Companies›Biotech & Pharma›Eletala

Eletala Enterprises Inc

Develops a leucovorin formulation for people with autism spectrum disorder.

No LinkedIn page we could confirm. Why?
Updated Nov 16, 2026·Latest SEC filing Jan 22, 2026·Suggest an edit

About Eletala

Eletala is a private company based in Wilmington, Delaware, incorporated in 2025 in Delaware. It has reported $100,000 raised in one offering on Form D since January 2026. Its chief executive is Richard Frye.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 11, 2026Jan 22, 2026$100,000of $10.0M target1$100KSecurities on exercise, Simple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Eletala's Form D filed Jan 22, 2026.

SV
Sri Venkatesh
Executive officer and director
JG
John Gaitanis
Executive officer and director
Richard Frye
Richard Frye
Ceo/cso and director

Sources

  1. SECEletala Enterprises Inc filing history
  2. CompanyEletala press release